Tilray Inc (NASDAQ:TLRY) has received an average rating of “Hold” from the sixteen research firms that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $81.17.
Several equities research analysts have weighed in on the stock. Jefferies Financial Group set a $61.00 target price on shares of Tilray and gave the stock a “sell” rating in a report on Tuesday, March 19th. Piper Jaffray Companies set a $90.00 target price on shares of Tilray and gave the stock a “buy” rating in a report on Tuesday, March 19th. Stifel Nicolaus assumed coverage on shares of Tilray in a report on Wednesday, June 5th. They issued a “hold” rating and a $37.00 target price on the stock. BMO Capital Markets upgraded shares of Tilray from an “underperform” rating to a “market perform” rating and set a $50.58 target price on the stock in a report on Wednesday, May 15th. Finally, Alliance Global Partners assumed coverage on shares of Tilray in a report on Monday, May 13th. They issued a “neutral” rating and a $50.00 target price on the stock.
NASDAQ TLRY traded up $0.17 during trading hours on Wednesday, hitting $47.15. The company’s stock had a trading volume of 27,125 shares, compared to its average volume of 2,013,352. The stock has a fifty day moving average of $43.29. Tilray has a twelve month low of $20.10 and a twelve month high of $300.00. The firm has a market cap of $4.53 billion and a price-to-earnings ratio of -57.41. The company has a quick ratio of 2.06, a current ratio of 2.35 and a debt-to-equity ratio of 1.13.
Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Tuesday, May 14th. The company reported ($0.27) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.25) by ($0.02). Tilray had a negative net margin of 159.09% and a negative return on equity of 43.71%. The business had revenue of $23.00 million during the quarter, compared to analyst estimates of $20.50 million. The business’s quarterly revenue was up 194.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Tilray will post -0.89 EPS for the current year.
In other news, Director Christine St.Clare sold 4,000 shares of the stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $50.01, for a total transaction of $200,040.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Mark Castaneda sold 10,000 shares of the stock in a transaction on Monday, April 15th. The stock was sold at an average price of $51.72, for a total transaction of $517,200.00. The disclosure for this sale can be found here. 3.40% of the stock is owned by corporate insiders.
Several hedge funds have recently modified their holdings of TLRY. Zevenbergen Capital Investments LLC increased its position in shares of Tilray by 37.1% during the first quarter. Zevenbergen Capital Investments LLC now owns 730,280 shares of the company’s stock worth $47,848,000 after acquiring an additional 197,540 shares in the last quarter. Hellman Jordan Management Co. Inc. MA bought a new stake in shares of Tilray during the first quarter worth $3,276,000. Stevens Capital Management LP bought a new stake in shares of Tilray during the first quarter worth $2,106,000. Park West Asset Management LLC bought a new position in Tilray in the fourth quarter valued at $2,244,000. Finally, D. E. Shaw & Co. Inc. bought a new position in Tilray in the fourth quarter valued at $2,119,000. 2.10% of the stock is owned by institutional investors.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Recommended Story: CD Ladder
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.